AN2 Therapeutics, Inc.
ANTX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $18 | $18 | $20 | $21 |
| Short-Term Investments | $44 | $45 | $47 | $62 |
| Receivables | $0 | $3 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $2 | $2 | $2 |
| Total Curr. Assets | $64 | $68 | $70 | $86 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $3 | $8 | $11 | $5 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $1 |
| Total NC Assets | $3 | $8 | $12 | $6 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $67 | $76 | $81 | $92 |
| Liabilities | – | – | – | – |
| Payables | $2 | $2 | $3 | $3 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $0 | $5 | $7 |
| Total Curr. Liab. | $2 | $2 | $8 | $10 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $5 | $5 | $0 | $0 |
| Total NC Liab. | $5 | $5 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $7 | $7 | $8 | $10 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$232 | -$223 | -$216 | -$206 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $293 | $292 | $290 | $288 |
| Total Equity | $60 | $69 | $73 | $82 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $67 | $76 | $81 | $92 |
| Net Debt | -$18 | -$18 | -$20 | -$21 |